IRCT201312102480N3已完成未知
Evaluating the effect of a combination of insulin resistance reducing agents pre and post coronary artery bypass grafting surgery on post-operative blood glucose and oxidative stress regulation, Shiraz, 2012.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 70 years（—）
- 性别
- All
入选标准
- •male and female patients in the range of 30 to 70 years old, undergoing coronary artery bypass grafting surgery,
- •exclusion criteria: Diabetes mellitus, Metabolic, hematological, and immune disorders, history of renal problem and CVA, taking antioxidant supplements, emergency operations, ejection fraction < 30%
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Effect of synbiotic in treatment of diabetesIRCT20220313054269N1Islamic Azad University, Science and Research Branch76
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-HUovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002878-47-ESovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-SKovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002878-47-GRovo Nordisk A/S64